Macrophage colony-stimulating factor (M-CSF) is a hemopoietic cytokine with a primary role in placental physiology. Gene expression of M-CSF in the bovine endometrium shows a temporal upward trend during early and mid pregnancy. This study determined the plasma M-CSF levels during pregnancy using ELISA. In experiment 1, to investigate the relationship between the concentration of M-CSF in peripheral blood and pregnancy, the plasma M-CSF levels were determined in 125 pregnant and 21 non-pregnant Japanese Black cows. The pregnant animals were divided into nine groups based on the month of pregnancy. An ELISA for bovine M-CSF established previously was used according to the authors' instructions. In experiment 2, the plasma M-CSF level was determined to investigate the temporal changes in its concentration in the peripheral blood during pregnancy. In experiment 1, the plasma M-CSF level varied from month to month during pregnancy; the mean level in the first-month of pregnancy was significantly higher than those in the third and last months of pregnancy and non-pregnancy (P<0.05). In experiment 2, the plasma M-CSF level varied with the day of pregnancy (P<0.05). The mean level of plasma M-CSF decreased gradually until 6 weeks of pregnancy; it appeared to increase during weeks 7-9, then varied with several small peaks until 27 weeks of pregnancy and finally decreased gradually until parturition. These results suggest that the plasma M-CSF level may be related to changes in the uterus and placenta as pregnancy progresses.
Macrophage colony-stimulating factor (M-CSF) is a hemopoietic cytokine that regulates the proliferation of hemopoietic stem cells and their differentiation into macrophages [30] . Moreover, M-CSF plays an important role in the establishment and maintenance of pregnancy. Female homozygous M-CSF-deficient osteopetrotic (op/op) mutant mice exhibit greatly reduced rates of fertility; however, successful pregnancy is not completely blocked [22] . M-CSF is synthesized in the uterus of pregnant mice, and the uterine M-CSF concentration increases 1,000-fold by term [2, 21, 25] . Expression of the gene encoding M-CSF is first detected in the mouse uterine epithelium prior to implantation on day 3 of pregnancy and subsequently increases, reaching a peak at day 14 or 15 of pregnancy [1] . There are two forms of M-CSF mRNA in the mouse uteroplacental unit, corresponding to protective fragments of 1,400 and 263 base pairs (bp). In the previous study of uteroplacental units in mice suffering pregnancy loss induced by treatment with cyclophosphamide, the level of the 1,400 bp mRNA form decreased by 40% compared with control mice, and the level of the 263 bp mRNA decreased by about 20% in resorbing mice compared with non-resorbing mice [5] . There are also reports describing changes in the serum M-CSF level in pregnant mice. The concentration of serum M-CSF is elevated between days 5 and 10 of pregnancy [2] .
There is no significant difference in the concentration of serum M-CSF between day 17 of pregnancy and day 3 of the post-pregnancy period [26] .
In contrast, human endometrial, decidual and placental tissues have been found to express M-CSF mRNA and have demonstrated extractable immunoreactive M-CSF [8, 12, 13] . Human M-CSF, in a concentration-dependent manner, increases the secretion of human chorionic gonadotropin from primary cultured human cytotrophoblastic cells and a human placental cell line [27] . Amniotic fluid M-CSF is one of the regulators of human placental development and is related to fetal growth [18] . The serum M-CSF level in pregnant women has been found to be higher than that in non-pregnant women [7, 16, 24, 28, 31, 32, 34, 36] . In addition, it has been found that the high level of M-CSF in the peripheral blood of pregnant women is caused by M-CSF production in the human placenta [9, 11, 20] and endometrium [23, 36] . These findings suggest that M-CSF plays an important role in human and mouse pregnancy.
Furthermore, expression of an M-CSF receptor-like protein has been demonstrated on postattachment bovine trophoblasts between Day 29 and term and on preattachment bovine conceptuses flushed at Days 7 and 14 of pregnancy using a monoclonal antibody to feline M-CSF receptor [3] . The gene for M-CSF has been detected in the bovine endometrium during the estrous cycle and early and mid pregnancy [17, 19] . These findings suggest that M-CSF may play a role in bovine pregnancy. Recently, an ELISA system for quantitation of bovine M-CSF was established, and the serum M-CSF levels of bovine fetuses and calves were measured [37] . However, there has been no investigation into the pattern of the plasma M-CSF concentration during pregnancy. Elucidation of the function of M-CSF during pregnancy is important in order to reveal the major mechanisms of pregnancy and thus improve bovine reproductive performance. The objective of this study was to determine plasma M-CSF levels during pregnancy using ELISA.
MATERIALS AND METHODS

Experiment 1: Plasma M-CSF levels in pregnant and non-pregnant cows:
One hundred and forty-six Japanese Black cows (125 pregnant and 21 non-pregnant) aged between 1.5 and 10.0 years were used to study plasma M-CSF levels using an ELISA for bovine M-CSF. All 125 pregnant cows had conceived via AI and were divided into nine groups according to the month of pregnancy: first (n=12), second (n=18), third (n=10), fourth (n=16), fifth (n=15), sixth (n=18), seventh (n=12), eighth (n=12), and ninth and last (n=12) months. All 21 non-pregnant cows were not inseminated in the present estrous cycle. Ten milliliters of peripheral blood was collected from the jugular vein into a heparinized tube. The plasma sample was collected by centrifugation (4°C, 3,000 rpm, 30 min) and kept at -30°C until the time of the assay.
To evaluate the correlation between the serum and plasma M-CSF levels, serum samples were collected from 48 pregnant and 11 non-pregnant cows, which were selected from the 146 cows. To obtain a serum sample, 10 ml of peripheral blood was collected from the jugular vein into Venoject ® II Autosep ® blood collection tubes (Terumo, Tokyo, Japan), and the tubes were held for 15 min at room temperature. The serum sample was collected by centrifugation (15°C, 3,000 rpm, 30 min) and kept at -30°C until the assay was conducted.
Experiment 2: Temporal change in plasma M-CSF levels during pregnancy: Six cows aged between 1.3 and 2.7 years were used to study the temporal changes in the plasma M-CSF levels during pregnancy. The plasma samples for ELISA were obtained every 1 and/or 2 weeks from 2 weeks before pregnancy to 5 weeks after parturition. Ten milliliters of peripheral blood was collected from the jugular vein into heparinized tubes. The plasma sample was obtained by centrifugation (4°C, 3,000 rpm, 30 min) and kept at -30°C until the time of the assay.
ELISA for bovine M-CSF: The procedure for the ELISA for bovine M-CSF was conducted as described previously [35] . The ELISA plates (Nunc, Roskilde, Denmark) were coated with 100 µl of coating solution (5 µg/ml of anti- ml in TBS-T) was added, and the plates were incubated for 1 hr at room temperature. The plates were washed four times, incubated for 1 hr at room temperature with 100 µl biotin-conjugated goat anti-rabbit IgG antibody (BioSource, Camarillo, CA, U.S.A.), diluted 1/20,000 in TBS-T, and again washed four times. One hundred microliters of alkaline phosphatase (AP)-conjugated streptavidin (Vector Laboratories, Inc., Burlingame, CA, U.S.A.) diluted 1/1,000 in TBS-T was added, and the plates were incubated for 1 hr at room temperature. After four washings, the AP activity retained in the wells was assayed by addition of 100 µl of ρnitrophenyl phosphate (Sigma, St. Louis, MO, U.S.A.) for 15 min at room temperature. The reaction was stopped by adding 50 µl of 150 mM ethylenediaminetetraacetate (EDTA), and the absorbance was measured at 405 nm with a Biomek Plate Reader (Beckman Coulter, Fullerton, CA, U.S.A.). The sensitivity range of this ELISA was from 0.1 to 40 ng/ml. The intra-and interassay coefficients of variance were 3.6% and 14.7%, respectively.
Statistical analysis: Data from experiment 1 were analyzed by one-way ANOVA and Tukey-Kramer's honestly significant difference (HSD) test using JMP TM (SAS Institute Inc., Cary, NC, U.S.A.), and data from experiment 2 were analyzed by General Linear Model (GLM) and Tukey's multiple comparison test using SAS (SAS Institute Inc.). Correlation between the plasma and serum M-CSF levels in experiment 1 was evaluated by Pearson's correlation coefficient using JMP TM . SAS was used with the assistance of the Computer Center for Agriculture, Forestry and Fisheries Research, MAFF, Japan.
RESULTS
The results of Experiment 1 are shown in Fig. 1 and Table  1 . The plasma M-CSF concentrations in the pregnant cows ranged from 0.1 to 4.5 ng/ml (average 1.06 ng/ml), whereas the concentrations in the non-pregnant cows ranged from 0.1 to 1.8 ng/ml (average 0.52 ng/ml). The M-CSF concentrations varied widely throughout pregnancy. The concentrations in the non-pregnant cows did not correlate with the days of the estrous cycle (r= -0.02), and there were no significant differences in the mean concentrations at four different stages: the estrus (day 0), early luteal (days 1 to 6), mid-luteal (days 7 to 16) and luteal regression (day 17 to the next estrus) phases. The mean concentration of plasma M-CSF in the first month of pregnancy was 1.70 ng/ml; this was the highest concentration measured at any time point. The mean concentration of plasma M-CSF decreased in the second and third months of pregnancy, and then the mean concentration increased and stabilized at about 1.00 ng/ml between the 4th and 8th months of pregnancy. Subsequently, the mean concentration of plasma M-CSF decreased again in the 9th and last months of pregnancy. The mean plasma concentration of M-CSF in the first month of pregnancy was significantly higher than those in the third and last months of pregnancy and in the non-pregnant cows (P<0.05).
The correlations between serum and plasma M-CSF concentrations are shown in Fig. 2 . There was moderate correlation (r=0.49) between the serum and plasma M-CSF concentrations in 59 cows (48 pregnant, 11 non-pregnant; r=0.46 and 0.66, respectively). Thus, measurement of plasma M-CSF may be useful for investigating changes in M-CSF in maternal peripheral blood.
The results of Experiment 2 are shown in Fig. 3 . The plasma M-CSF concentrations ranged from 0.1 to 4.3 ng/ml (average 1.05 ng/ml) and varied throughout pregnancy. The mean concentration of plasma M-CSF 2 weeks before AI was 1.79 ng/ml; this was the highest value for all the sampling points in Experiment 2. The mean concentration of plasma M-CSF stabilized with high concentrations between 1 week before and 2 weeks after AI and then decreased until 6 weeks of pregnancy. Subsequently, the mean concentra-tion of plasma M-CSF increased and remained high, with several small increases and decreases until 27 weeks of pregnancy. The concentration then gradually decreased until parturition. The concentration increased temporarily and slightly at parturition. After parturition, the mean plasma M-CSF concentration remained low. There were significant differences in the plasma M-CSF concentrations according to the period of pregnancy (P<0.05). For example, the plasma M-CSF concentration 2 weeks before pregnancy was higher than the concentrations from 4 to 6 weeks, at 35 and 36 weeks, from 38 to 41 weeks of pregnancy, at parturition and from 1 to 5 weeks postpartum.
DISCUSSION
A number of researchers have reported that M-CSF and its receptor are expressed in the female reproductive tract and that M-CSF plays an important role in pregnancy in mice [1, 2, [21] [22] [23] , humans [8, [11] [12] [13] , pigs [35] and cows [3, 17, 19] . Furthermore, M-CSF concentrations in maternal peripheral blood during the estrous cycle and pregnancy have been reported in humans and mice. In humans, M-CSF concentrations in maternal peripheral blood increase as pregnancy progresses, peak at term and then decrease immediately after parturition until they reach the base level of non-pregnancy [7, 9, 16, 24, 28, 31, 32, 34, 36] . Ishii et al. reported that M-CSF in maternal peripheral blood is produced in the uterus, placenta and peripheral monocytes and that M-CSF of uterine and placental origin is related to a high concentration of maternal serum M-CSF [9] . Furthermore, it has been reported that low concentrations of serum M-CSF are associated with unexplained recurrent spontaneous abortion in humans [4, 14] . In contrast, the increase in M-CSF concentrations in the peripheral blood of pregnant females at term is about twice that of the concentration in non-pregnant mice [2, 23] . In addition, Pollard et al.
reported that the murine serum M-CSF concentration does not increase during pregnancy [21] . From these findings, it appears that the relationship between pregnancy and the M-CSF concentration in peripheral blood differs according to species. The objective of this study was to investigate the variation in M-CSF concentrations in peripheral blood during pregnancy in the Japanese Black cow. Moderate correlations between the serum and plasma M-CSF concentrations in pregnant and non-pregnant cows were found in the present study. Although the plasma M-CSF concentrations tended to be lower than the serum concentrations, we believe that the plasma M-CSF concentration can be used as an index of the M-CSF concentration in peripheral blood. In Experiment 1, the plasma M-CSF concentration ranged from 0.1 to 4.5 ng/ml, and the mean ± SD M-CSF concentrations in the pregnant and non-pregnant cows were 1.06 ± 0.8 and 0.52 ± 0.42 ng/ml, respectively. Yoshihara et al. reported that the serum M-CSF concentration in calves 0 to 1 days after birth ranged from 0.52 to 7.3 ng/ml, and the mean ± SD M-CSF concentration in pregnant cows between 150 and 280 days of pregnancy was 4.1 ± 0.48 ng/ml [37] . In the present study, the mean plasma M-CSF concentrations between 150 and 280 days of pregnancy ranged from 0.4 to 1.7 ng/ml, and the plasma concentrations showed a strong downward trend compared with the serum M-CSF concentrations in the earlier report. Although it is conceivable that differences in age, parity, strain and breed affect the M-CSF concentration, further investigation is needed.
The results of Experiments 1 and 2 indicated that bovine plasma M-CSF concentrations change during pregnancy. Plasma M-CSF concentrations remained high for several weeks after AI and then decreased temporarily in the first trimester. The concentrations increased again and remained relatively high during the second trimester and then decreased during the third trimester until parturition. There were close similarities between the patterns of change in the plasma M-CSF concentrations in Experiments 1 and 2, although there was a time lag at the first trough (month 3 in Experiment 1 and week 6 in Experiment 2) and little difference between the results of the two experiments. It is conceivable that the major cause of these differences may have been the wide variation in the plasma M-CSF concentration within individual cows. In addition, the plasma M-CSF concentrations 2 weeks before AI were higher than in the other periods in Experiment 2. Furthermore, the mean plasma M-CSF concentration before AI in Experiment 2 tended to be higher than that of the non-pregnant cows in Experiment 1. These findings suggest that plasma M-CSF concentrations vary during the estrous cycle. In human nonpregnant endometrial tissues, the tissue-extractable level of immunoreactive M-CSF in secretory endometrial tissue is higher than that in proliferative endometrial tissue [15] . Furthermore, progesterone has a dose-dependent effect on M-CSF production by the stromal cell-enriched fraction of the human non-pregnant endometrium in vitro [13] . M-CSF has several isoforms, and bovine M-CSF is expressed mainly as 3-and 4-kb transcripts; the 3-kb mRNA encodes the membrane-bound form, and the 4-kb mRNA encodes the secreted form. The ratio of the 4-to 3-kb forms in the non-pregnant endometrium showed dynamic variation during the estrous cycle; the ratio was 1.0 to 1.3 in the first 4 days of the cycle, it decreased significantly on days 14 and 17 and then it subsequently increased significantly during the 3 days leading to estrus (days 19 to 21). The variation is reflected in the relative concentrations of progesterone and estrogen [17] . It may be that steroid hormones are related to bovine M-CSF production and plasma M-CSF concentrations during the estrous cycle and gestation periods, but further investigation is needed in this regard.
The concentration of M-CSF tended to remain high in the first month after parturition. In cattle, the first month of pregnancy has several important characteristics: maternal recognition of pregnancy takes place around day 16, implantation occurs around day 20, the primary placentome is formed at about 30 days of pregnancy and the conceptus in the uterus develops markedly during this period [6, 10, 29] . It is conceivable that the M-CSF concentration in the maternal peripheral circulation may reflect these phenomena of early pregnancy. In the pregnant endometrium, expression of the 4-kb secreted form in the gravid horn increases from about day 17 of pregnancy, and the predominant increase in this form leads to an exponential increase in the expression of M-CSF mRNA during pregnancy [17] . Furthermore, a small increase in M-CSF gene expression in the pregnant endometrium is observed on days 20 to 21 of pregnancy, although the increase is not significant [19] . These 2 reports support the relation between the plasma M-CSF concentration in the first month of pregnancy and the increase in M-CSF secretion from the endometrium during the period of maternal recognition and primary placentome formation.
A transient downward trend in plasma M-CSF was observed during early pregnancy. In our previous report, M-CSF gene expression in the caruncular and intercaruncular endometrium showed a transient downward trend, reaching a minimum between days 30 and 36 of pregnancy; however, the decrease was not significant [19] . Furthermore, the frequency of M-CSF receptor-positive cells appears to decrease temporally in the intercotyledonary region of the conceptus during days 45 to 95 [3] . These findings suggest the possibility that M-CSF gene expression in the pregnant endometrium in early pregnancy decreases temporarily during certain periods after implantation, and the change in the plasma M-CSF concentration reflects that of M-CSF gene expression in the endometrium. Subsequently, the plasma M-CSF concentration increases again and remains high during the second trimester. Lee et al. reported an exponential increase in M-CSF gene expression in the endometrium that is caused by a predominant increase in the secreted form of M-CSF beginning at 50 days of pregnancy [17] . In addition, M-CSF gene expression in the intercaruncular endometrium increases significantly during days 74 to 140 of pregnancy [19] . Furthermore, the frequency of M-CSF receptor-positive trophoblast cells appears to increase during days 96 to 190 of pregnancy [3] . On the basis of these findings, the changes in plasma M-CSF concentrations in Experiments 1 and 2 also appear to reflect the production of M-CSF in the pregnant endometrium and placenta.
The plasma M-CSF concentrations decreased gradually in the third trimester. We speculated that the change in bovine plasma M-CSF in the last trimester reflects a response to parturition and that uterine and placental M-CSF synthesis declines in this period. The frequency of M-CSF receptor-positive trophoblast cells appears to be lower during days 191 to 280, the last trimester of bovine pregnancy, than during the other stages of pregnancy [3] . In the last trimester, M-CSF expression and synthesis in the endometrium and placenta may decrease in response to the low frequency of M-CSF receptor-positive trophoblast cells.
In humans, the maternal serum M-CSF concentration increases during pregnancy and reaches the maximum in the period just before parturition, mainly because of uterine and placental synthesis induced by progesterone and estrogen [24, 36] . Progesterone, present in high concentrations at the feto-maternal interface, promotes development of T cellproducing M-CSF at the feto-maternal interface [20] . Furthermore, Gargiulo et al. reported that M-CSF concentrations in cervicovaginal lavage supernatant correlate well with estradiol concentrations in peripheral serum and with the ratio of estradiol to progesterone during the menstrual cycle [4] . The possibility exists that bovine placental and endometrial M-CSF production is regulated by progesterone and estrogen. This view is supported by the observation by Lee et al. that the dynamic variation in M-CSF mRNA expression and the ratio of the 4-and 3-kb forms during early pregnancy are related to the concentrations of progesterone and estrogen [17] . In cattle, the peripheral concentration of plasma estrone sulfate (E1-S), predominant among the conjugated steroids throughout pregnancy, increases gradually from about 100 days of pregnancy and peaks at about 10 days before parturition [33] . It is conceivable that the ratio of estrogen to progesterone in the peripheral circulation, endometrium and placenta changes with advancement of pregnancy. The plasma E1-S concentration appears to increase largely in the last trimester, especially in the last month of pregnancy. The interplay between estrogen and progesterone may be related to the changes in the plasma concentration of M-CSF.
In conclusion, the changes in plasma M-CSF concentrations observed in the present study reflect the changes that occur in the peripheral blood of Japanese Black cows undergoing normal pregnancy. The results suggest that the variation in M-CSF concentrations in the peripheral blood of pregnant cows may reflect M-CSF synthesis in the endometrium and placenta during pregnancy.
